2024-12-10 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Review

**1) Performance Comparison & Divergence:**

Teladoc Health Inc (TDOC) is a telehealth company providing virtual care services.  The provided data shows a cumulative return of `nan` for TDOC, while the S&P 500 (VOO) shows a cumulative return of 121.38%.  This represents a significant negative divergence.  The provided iikgeokdo (presumably a measure of divergence) shows a current value of -183.9,  with a range of -187.9 to 710.7 and a relative divergence of 0.4.  This indicates TDOC has significantly underperformed the S&P 500.


**2) Current Stock Price:**

The closing price is $11.0, with a last market price of $10.7.


**4) Recent Earnings Analysis:**

The provided earnings data reveals several trends:

* **Latest Quarterly Results Comparison:**  The most recent quarter (2024-10-31) shows an EPS of -0.19 and revenue of $0.64B. Compared to the previous quarter (2024-08-01), EPS improved significantly from -4.92 to -0.19, while revenue remained relatively stable.  However, it is worth noting that there's a duplicate entry for 2024-10-31.

* **Revenue Growth Trends:** Revenue has remained relatively flat around $0.64B-$0.66B over the past few quarters, showing minimal growth.

* **EPS Trends and Significant Changes:** EPS has fluctuated significantly, showing substantial losses in all reported quarters. The improvement from Q2 2024 to Q3 2024 is noteworthy but still represents a substantial loss.

* **Beats or Misses:**  No information on expectations is provided, therefore, beats or misses cannot be assessed.


**5) Financial Information Analysis:**

**Revenue and Profitability:** Revenue is relatively stable but shows no significant growth.  Profit margins are consistently high (around 70%), suggesting operational efficiency despite significant losses. This high margin despite losses may indicate high operational leverage.

**Capital and Profitability:** Equity has fluctuated but generally remained high. ROE is consistently negative and highly volatile, indicating substantial losses relative to equity. The significant drop in ROE from Q1 2024 to Q2 2024 is particularly concerning.


**6) News and Recent Issues:**

No recent news (within the last two days) or analyst opinions are provided.  The market outlook for TDOC is implicitly negative, given its underperformance against the S&P 500.


**7) Overall Analysis:**

TDOC has significantly underperformed the S&P 500. While revenue remains relatively stable and profit margins are high, the company is reporting substantial losses reflected in a consistently negative ROE.  The recent improvement in EPS is positive, but the overall picture shows a company struggling to translate revenue into profitability.  Further information regarding market expectations and recent news is required for a more comprehensive analysis.  The high volatility in both EPS and ROE highlight significant uncertainty surrounding the company's future performance.  More data is needed to fully evaluate if the recent improvements in EPS are sustainable.


**8)  Disclaimer:** This analysis is based solely on the provided data.  It does not constitute financial advice.  Investing in the stock market involves risk, and past performance is not indicative of future results.  Conduct thorough independent research before making any investment decisions.
